On January 9, the FDA warned seven compounding pharmacies to cease marketing estrogen/progestin products containing estriol. The FDA also warned the pharmacies to stop making claims that the compounded products could be used to treat Alzheimer’s disease, breast cancer, depression, and colon cancer. The FDA also demanded that the pharmacies…
Updated: